You are here:    Home For Scientists CTF RAB Research Advisory Board (RAB) 2007-2008

ja_mageia

For scientists
PDF Print E-mail

All Foundation sponsored research is based on a rigorous peer review process, performed by the Foundation's Peer Review Panel, the Research Advisory Board (RAB) which consists of leading researchers in the field of NF.

All Foundation sponsored research is based on a rigorous peer review process, performed by the Foundation's Peer Review Panel, the Research Advisory Board (RAB) which consists of the following:

YOUNG INVESTIGATOR AWARD COMMITTEE

CO-CHAIRPERONS
Dr. Margaret Wallace
University of Florida

Dr. Andrea I. McClatchey
Harvard Medical School / MGH Cancer Center
MEMBERS

Dr. Stuart A. Aaronson
Mount Sinai School of Medicine

Dr. Andre Bernards
Harvard University/Massachusetts General Hospital

Dr. Adrienne D. Cox
University of North Carolina at Chapel Hill

Dr. Florent Elefteriou
Center for Bone Biology

Dr. Rick Fehon
Duke University

Dr. Cristina Fernandez-Valle
University of Central Florida

Dr. Michael J. Fisher
Children's Hospital of Philadelphia

Dr. Cynthia M. Hingtgen
Indiana University School of Medicine

Dr. David A. Ingram
Indiana University School of Medicine

Dr. Joseph Kissil
The Wistar Institute

Dr. Bruce Korf
University of Alabama, Birmingham School of Medicine

Dr. Dimitra Mangoura
Institute for Biomedical Research of the Academy Athens

Dr. Shyra Miller
Children's Hospital Medical Center

Dr. Anat Stemmer-Rachamimov
Massachusetts General Hospital

Dr. Vijaya Ramesh
Harvard Medical School / Massachusetts General Hospital

Dr. Karlyn Reilly
National Cancer Institute at Frederick

Dr. David Stevenson
University of Utah

Dr. Sheila M. Thomas
Harvard Medical School/ Cancer Biology Program

Dr. James H. Tonsgard
University of Chicago Hospitals

Dr. Dave Viskochil
University of Utah

Dr. Kristine S. Vogel
Medical School Building, HSC-MED

Dr. Yuan Zhu
University of Michigan Medical School


DRUG DISCOVERY INITIATIVE REVIEW COMMITTEE
CHAIR
Dr. David H. Gutmann
Washington University School of Medicine

MEMBERS
Dr. Gideon E. Bollag
Plexxikon Inc.

Dr. Karen Cichowski
Harvard Medical School / Brighatm & Women's Hospital

Dr. D. Wade Clapp
Indiana University School of Medicine

Dr. Sara A. Courtneidge
The Burnham Institute for Medical Research

Dr. Channing J. Der
University of North Carolina at Chapel Hill

Dr. Jay Gibbs
AstraZeneca Pharmaceuticals

Dr. Janet M Hock
Maine Inst Human Genetics and Health

Dr. Frank McCormick
University of San Francisco Cancer Center

Dr. Michael Morin
Pfizer, Inc.

Dr. Peter Phillips
Children?s Hospital of Philadelphia

Dr. David Stokoe
University of California, San Francisco

Dr. Kevin Shannon
University of California, San Francisco

Dr. Kathy Warren
National Cancer Institute

Dr. Brigitte C. Widemann
National Cancer Institute


EMERITUS REVIEWERS
Dr. Anthony B. Bretscher
Cornell University

Dr. John C. Carey
University of Utah

Dr. Jonathan Epstein
University of Pennsylvania

Dr. James F. Gusella
Harvard University/Massachusetts General Hospital

Dr. Tyler Jacks
M.I.T., Center for Cancer Research

Dr. William G. Johnson
UMDNJ-Robert Wood Johnson Medical School

Dr. Robert L. Martuza
Harvard University/Massachusetts General Hospital

Dr. Luis Parada
University of Texas/Southwestern Medical Center

Dr. Nancy Ratner
University of Cincinnati
 

Upcoming Events

NF FORUM 2010 - LAS VEGAS
04-09-2010 - 04-11-2010

Neurofibromatosis Type 2 Meeting
05-02-2010 - 05-04-2010

"BEN"EFIT FOR NF2 - Hosted by the Monterotti Family
05-02-2010

New York: New York City Poker
05-06-2010

2010 Annual NF Conference
06-05-2010 - 06-09-2010

Dancing With Our Stars
09-19-2010

Strategic Planning and Research Oversight
How does the Foundation plan and manage our funded research programs?
NF Clinic Network
The CTF-NFCN aims to ultimately improve clinical care for those living with NF1, NF2 or Schwannomatosis, promote information sharing between NF Clinics, and integrate NF clinical care, research and clinical trials.  
Drug Discovery Initiative
A Preclinical Consortium, Grant Awards and Toolbox to Accelerate Candidate NF Drug Screening
NF Conference
Find out about the premier annual event on the neurofibromatosis research and clinical calendar, bringing together over 200 clinicians and researchers from around the world to present the latest developments in NF research and clinical care.
Young Investigator Awards
An opportunity for young researchers to get involved in the field of NF research.
Meetings and Symposia
The Foundation organizes and participates in scientific meetings, large and small to further the collective knowledge and understanding of NF.
NF Clinical Trial Award
Clinical Trial Awards of up to $125,000 total award are available to support pilot-scale clinical testing of potential candidate therapeutics for the treatment of tumors and other manifestations of NF1, NF2 or Schwannomatosis.
Medical Podcasts
Listen to leading experts in NF talk about where we are today and where we're headed in the pursuit of treatments and a cure for NF.
Schwannomatosis Awards
The Children’s Tumor Foundation is at the forefront of advancing knowledge about Schwannomatosis, a rare form of NF affecting 1:40,000 persons. Our Schwannomatosis Awards program is funding vital research and driving collaboration between scientists and physicians.
Congressionally Directed Medical Research Program
Learn about funding opportunities from the Department of Defense's Neurofibromatosis Research Program